322 related articles for article (PubMed ID: 29123259)
1. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.
Kitano Y; Okabe H; Yamashita YI; Nakagawa S; Saito Y; Umezaki N; Tsukamoto M; Yamao T; Yamamura K; Arima K; Kaida T; Miyata T; Mima K; Imai K; Hashimoto D; Komohara Y; Chikamoto A; Ishiko T; Baba H
Br J Cancer; 2018 Jan; 118(2):171-180. PubMed ID: 29123259
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.
Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K
Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients.
Kitano Y; Yamashita YI; Nakao Y; Itoyama R; Yusa T; Umezaki N; Tsukamoto M; Yamao T; Miyata T; Nakagawa S; Okabe H; Imai K; Chikamoto A; Ishiko T; Baba H
Ann Surg Oncol; 2020 Feb; 27(2):599-607. PubMed ID: 31407173
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Saito Y; Nakagawa S; Okabe H; Imai K; Komohara Y; Miyamoto Y; Chikamoto A; Ishiko T; Baba H
World J Surg; 2019 Sep; 43(9):2271-2280. PubMed ID: 31041559
[TBL] [Abstract][Full Text] [Related]
5. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
6. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
8. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
[TBL] [Abstract][Full Text] [Related]
9. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N
Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma.
Lan C; Kitano Y; Yamashita YI; Yamao T; Kajiyama K; Yoshizumi T; Fukuzawa K; Sugimachi K; Ikeda Y; Takamori H; Miyanari N; Hirota M; Baba H
Br J Cancer; 2022 Feb; 126(2):219-227. PubMed ID: 34616011
[TBL] [Abstract][Full Text] [Related]
11. Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma.
Lomphithak T; Akara-Amornthum P; Murakami K; Hashimoto M; Usubuchi H; Iwabuchi E; Unno M; Cai Z; Sasano H; Jitkaew S
Sci Rep; 2021 Jun; 11(1):11743. PubMed ID: 34083572
[TBL] [Abstract][Full Text] [Related]
12. Effective Predictor of Colorectal Cancer Survival Based on Exclusive Expression Pattern Among Different Immune Cell Infiltration.
Xu X; Ma J; Yu G; Qiu Q; Zhang W; Cao F
J Histochem Cytochem; 2021 Apr; 69(4):271-286. PubMed ID: 33550891
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression in extrahepatic cholangiocarcinoma.
Walter D; Herrmann E; Schnitzbauer AA; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2017 Sep; 71(3):383-392. PubMed ID: 28419539
[TBL] [Abstract][Full Text] [Related]
14. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
Ye Y; Zhou L; Xie X; Jiang G; Xie H; Zheng S
J Surg Oncol; 2009 Nov; 100(6):500-4. PubMed ID: 19697355
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.
Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
Mod Pathol; 2021 Apr; 34(4):798-807. PubMed ID: 33077921
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma.
Yusa T; Yamashita YI; Okabe H; Nakao Y; Itoyama R; Kitano Y; Kaida T; Miyata T; Mima K; Imai K; Hayashi H; Baba H
Cancer Sci; 2022 Dec; 113(12):4048-4058. PubMed ID: 35611468
[TBL] [Abstract][Full Text] [Related]
18. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
19. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
[TBL] [Abstract][Full Text] [Related]
20. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
